The founding Board of Directors for Innovocracy consists of entrepreneurs who view the creation of Innovocracy as a start-up operation- not unlike those our system is funding. This approach means launching fast and constantly improving as we go. We believe that this helps us in understanding the motivations behind innovation and the Innovators.
Mikael Totterman, Chairman. Mr. Totterman is a serial entrepreneur and a founder of iCardiac Technologies. Prior to iCardiac Technologies Mr. Totterman was the Chief Operating Officer of VirtualScopics Inc. (NASDAQ: VSCP), a leading developer of image-based biomarkers for improving pharmaceutical development. During his tenure at VirtualScopics, he led several of rounds of venture capital funding as well as striking strategic investment relationships with Pfizer, Inc. and GE Healthcare. Additionally, he was instrumental in developing VirtualScopics original business plan and overseeing the growth of the organization. Earlier in his career, Mr. Totterman also served as a principal at 3Com Ventures, a $250 million venture capital fund based in Santa Clara, CA as well as building 3Com’s Network of Global Strategic Alliances with companies including Philips, Siemens, AT&T and British Telecom. He has also held positions at Boston Consulting Group as well as Gemini Consulting. Mr. Totterman received his Bachelor’s Degree in Engineering from Stanford University where he was a David Starr Jordan Scholar and his Masters of Business Administration from the Amos Tuck School at Dartmouth College.
Richard Glaser, Director. Richard Glaser started his career as an investment banker in Merrill Lynch's mergers and acquisitions department. He spent most of his career as a private equity investor, investing directly in growing companies and serving as director of numerous service, manufacturing and high tech companies. He has worked closely with entrepreneurs and business owners as an investor and advisor. Richard has been an adjunct professor at the Rochester Institute of Technology, teaching entrepreneurship to graduate students. He has also been active in the entrepreneurial and economic development community in Rochester. Richard co-founded and was president of Digital Rochester and was an original board member of the Greater Rochester Enterprise. He also served as a board member of the Venture Investors Association of New York and annual giving chair of Haverford College. Richard uses his experience as an investment banker, investor and entrepreneur to focus on providing clients with a diverse range of specialized services.
Ralph J. Dandrea, Director. Ralph Dandrea is President and founder of ITX Corp, a strategic business and technology solutions firm. For more than a decade, Mr. Dandrea has specialized in business and technology consulting. His extensive experience in executive information technology management for large implementations resulted in the development of several methodologies for the efficient delivery of professional services. In providing strategic IT planning for firms in such diverse industries as banking, healthcare, eCommerce, and ePublishing, and Mr. Dandrea creates linkage between organizations’ strategic goals and technology. Mr. Dandrea earned his Bachelor of Science degree in Finance from the Rochester Institute of Technology. He received his Master of Business Administration and Juris Doctor, from the State University of New York at Buffalo. He is currently certified as a Microsoft Certified Systems Engineer (M.C.S.E.).
Alex Zapesochny, Director. Mr. Zapesochny is a serial entrepreneur, experienced technology executive and attorney who is also a founder of iCardiac Technologies. Previously, as General Counsel and Director of Business Development for Lenel Systems International, a developer and global supplier of high-end software, products and services for the security industry, Mr. Zapesochny was part of a small executive management team that guided the company to extraordinary growth. The company expanded to serving over 10,000 organizations throughout 75 countries, including security-conscious entities such as Microsoft, Cisco, all three New York City-area airports, the Department of Homeland Security and over sixty percent of all Fortune 100 companies. The company’s financial growth earned it 39th place on Inc. magazine’s ranking of the nation’s fastest-growing privately-held companies, and Lenel was acquired for $440 million by United Technologies Corporation (NYSE: UTX) in March 2005. Mr. Zapesochny remained with UTC after the acquisition and continued in his legal and business development roles within the Lenel Systems subsidiary. In private practice, Mr. Zapesochny has provided legal and business counsel to early-stage companies. Mr. Zapesochny’s other experience includes being a trial attorney during his tenure as a New York City prosecutor, a policy division staff member in the Washington headquarters of a presidential campaign, and Co-Founder and Executive Director of an award-winning non-profit that expands the national registry of potential bone marrow and blood stem cell donors. Mr. Zapesochny received his undergraduate degree from Cornell University and graduate degrees from American University and the University of Oxford.
Alexandra Latypova, Director. Alexandra Latypova is serial entrepreneur and a founder of iCardiac Technologies. iCardiac Technologies is based on technology developed by students and faculty at the University of Rochester. The company has received in excess of $7 million in venture capital funding and currently serves 6 of the top 10 pharmaceutical companies in addition to a broad range of clients across North America, Europe and Asia. Prior to iCardiac Technologies, Ms. Latypova headed sales and business development at VirtualScopics, Inc., a technology spin out from the University of Rochester, which achieved peak market capitalization of over $200 million (NASDAQ: VSCP). During her tenure at VirtualScopics, she expanded the client portfolio from one lead customer, Pfizer, to 6 of the top-10 pharmaceutical companies as well as multiple smaller pharmaceutical and medical device clients. In addition, she has been responsible for developing project management organization at VirtualScopics and hiring and training several project managers and business development associates. Prior to VirtualScopics, Ms. Latypova was a Manager in healthcare practice at Analysis Group, Inc., a Boston-based economics, financial and strategy consultancy, where she advised pharmaceutical clients on a wide range of issues concerning product and market development, as well as provided economic analyses and expertise in pharmaceutical litigation cases. Ms. Latypova holds Masters of Business Administration degree from the Amos Tuck School at Dartmouth College.
Martin Edic, Director. Martin is co-founder and CEO of 24PageBooks Inc. and a founding partner at Wing Digital, a digital marketing agency. He has served as Director of Marketing for three software-as-a-service companies, Bluetie, Techrigy and Catertrax. Martin is the author of eight business and design books. He was a founding Board member of Digital Rochester Inc. and RochesterGrowth and is involved in economic development initiatives in the Greater Rochester NY area.
Anik Bose, Adviser. Anik Bose is a seasoned executive with experience in both information technology and biotechnology businesses. He has headed the business development functions at communications technology companies such as 3Com as well as biotechnology focused companies such as Monsanto. In his business development roles he has managed a $250MM corporate venture fund, spearheaded dozens of venture capital investments and executed numerous spin out transactions as well as several large M&A transactions over $1.4Bn in value. His venture investments include - Mesh Networks, Parthus, Cicada Semiconductor, Microtune, ADMTek, Atrica, Intransa, Sheer Networks, Air Prime, Yipes, Silicon Wave and Healthetec. On the communications technology side, Mr. Bose architected the launch of the fastest growing Asian networking company (H3C - 3Com's joint venture with Huawei), which achieved annual revenues of over $700 million and a market valuation of $1.8Bn within 36 months of launch. For Monsanto, Mr. Bose developed and implemented global biotech growth strategies targeted towards achieving a significant return on Monsanto's $10 billion of acquisitions. Mr. Bose is currently a partner at Benhamou Global Ventures. BGV is an early stage venture fund that assists entrepreneurs in building a new generation of high technology companies. Earlier in his career, Mr. Bose served as a Partner in the High Technology Practice of Deloitte Management Consulting in San Francisco. Mr. Bose holds a MBA from Boston College and BA in Economics from the University of Delhi, India.
David Shulman, Adviser. David is President of Wunderman New York. David joined Wunderman in 2010 after serving as chief digital officer for WPP’s Enfatico. Prior, David was managing director of Digitas Detroit, an office he founded and ramped up to a full-service 200-person office. During his nine-year tenure at Digitas, David held senior client leadership and new business development positions across the Digitas network in Boston, New York and London for clients such as General Motors, GlaxoSmithKline, InterContinental Hotels and American Express. David was brand strategy manager at Jaguar Cars, helping to introduce the S-Type through an award-winning campaign that included TV, print, direct response and digital. David also helped start software development firm Software MacKiev in Kiev, Ukraine. David has extensive experience in the U.S. and Europe managing cross-capability teams in a range of industries including travel, electronics, and insurance, pharmaceutical and automotive. David holds a B.A. in Psychology from the University of Massachusetts and an M.B.A. from the Amos Tuck School at Dartmouth College. He lives in New York with his wife, Valerie, and daughter Ariella. When he’s not working or traveling, you’ll find him running, rock climbing or skiing.
How It Works
Board of Directors